Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for Recurrent Acute Pancreatitis
NCT06185621Recruiting
- Sponsor
- Air Force Medical University
- Start
- Nov 2023
- Primary completion
- Nov 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of aspirin in acute pancreatitis (AP), sponsored by Air Force Medical University. Primary endpoint: The mean interval between two consecutive occurrences of acute pancreatitis during follow-up at 2 years. Started Nov 2023; status: recruiting.
02
Drugs
aspirin
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT06185621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06185621.